Meningococcal vaccines in China [PDF]
Human Vaccines and Immunotherapeutics, 2021 Meningococcal meningitis caused by Neisseria meningitidis is a reportable infectious disease in China, due to the high incidence of meningitis in the era before the availability of vaccines.
Miao Xu
exaly +7 more sources
Systematic literature review on the safety and immunogenicity of rotavirus vaccines when co-administered with meningococcal vaccines [PDF]
Human Vaccines & Immunotherapeutics, 2020 This study is aimed to review the published evidence on safety, immunogenicity, and efficacy of rotavirus vaccines when co-administered with meningococcal vaccines in infants. A systematic literature search was performed in four databases containing peer-
Priya Pereira +2 more
doaj +3 more sources
Concomitant administration of meningococcal vaccines with other vaccines in adolescents and adults: a review of available evidence [PDF]
Human Vaccines & Immunotherapeutics, 2019 Invasive meningococcal disease (IMD), a rapidly progressing and potentially fatal illness, disproportionately affects adolescents and young adults. While IMD is best prevented by vaccination, vaccine uptake in these groups is low.
Justine Alderfer +6 more
doaj +3 more sources
Suboptimal uptake of meningococcal vaccines among older adolescents: Barriers, solutions, and future research directions [PDF]
Human Vaccines & Immunotherapeutics, 2020 Over the past 15 y, several vaccines have been added to the recommended immunization schedule for adolescents in the United States. In addition to annual influenza vaccination, the Advisory Committee on Immunization Practices recommends tetanus ...
Linda M. Niccolai, Caitlin E. Hansen
doaj +3 more sources
Vaccines against Meningococcal Diseases
Microorganisms, 2020 Neisseria meningitidis is the main cause of meningitis and sepsis, potentially life-threatening conditions. Thanks to advancements in vaccine development, vaccines are now available for five out of six meningococcal disease-causing serogroups (A, B, C, W,
Mariagrazia Pizza +2 more
exaly +4 more sources
Meningococcal Vaccines: Current Status and Emerging Strategies
Vaccines, 2018 Neisseria meningitidis causes most cases of bacterial meningitis. Meningococcal meningitis is a public health burden to both developed and developing countries throughout the world.
Pumtiwitt C. McCarthy +2 more
doaj +3 more sources
Expert Review of Vaccines, 2002 The successful introduction of a protein-polysaccharide conjugate vaccine against serogroup C meningococci into the UK infant immunization schedule, in combination with a catch-up campaign for individuals less than 18 years of age, has seen virtually all group C disease eliminated in childhood.
Delia Bethell, Andrew J Pollard
exaly +6 more sources
Carbohydrate based meningococcal vaccines: past and present overview. [PDF]
Glycoconj J, 2021 Neisseria meningitidis is a major cause of bacterial meningitidis worldwide. Children less than five years and adolescents are particularly affected.
Berti F, Romano MR, Micoli F, Adamo R.
europepmc +2 more sources
Economic evaluation of meningococcal vaccines: considerations for the future. [PDF]
Eur J Health Econ, 2020 In 2018, a panel of health economics and meningococcal disease experts convened to review methodologies, frameworks, and decision-making processes for economic evaluations of vaccines, with a focus on evaluation of vaccines targeting invasive ...
Christensen H +17 more
europepmc +2 more sources
Exploring the Ability of Meningococcal Vaccines to Elicit Mucosal Immunity: Insights from Humans and Mice [PDF]
Pathogens, 2021 Neisseria meningitidis causes a devastating invasive disease but is also a normal colonizer of the human nasopharynx. Due to the rapid progression of disease, the best tool to protect individuals against meningococcal infections is immunization. Clinical
Elissa G. Currie, Scott D. Gray-Owen
doaj +2 more sources